StocksIlluminaILMN

ILMN

Illumina

226.30 18.23 (8.76%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
ILMN
ILMN
FeedStatsChartResearchNews
S
226.29
B
226.75

Overview

Prev Close226.30
Day's Range 208.01 - 231.23
52 Week Range 173.17 - 524.25
Average Volume (3m)1.5M
1-Year Return-56.82%
Beta1.0207
Market Cap35.6B
P/E Ratio45.44
Revenue4.69B
EPS-0.0815
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.707/03/202216/05/202227/07/2022200.00250.00300.00350.00400.00
Chart times in UTC
Sector
Health Technology
Industry Biotechnology
CEO Francis A. deSouza
Employees 9,800

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Illumina's revenues increased by 39.73% and amounted to 4.53B. Net income increased by 16.16% to 762.00M. Net assets increased by 128.80% to 10.74B and EPS increased from 4.43 to 5.04.
ILMN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
67.55%
Net Profit Margin
23.30%
Operating Margin
-5.71%
Return On Investment
13.68%
09/21
12/21
03/22
06/22
Total Revenue
1.11B
1.2B
1.22B
1.16B
Gross Profit
788M
857M
815M
767M
Operating Income
-446M
86M
184M
30M
Net Income
317M
112M
86M
-535M